2019
Burden of medical co‐morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy
Ambrosy AP, Stevens SR, Al‐Khalidi H, Rouleau JL, Bouabdallaoui N, Carson PE, Adlbrecht C, Cleland JGF, Dabrowski R, Golba KS, Pina IL, Sueta CA, Roy A, Sopko G, Bonow RO, Velazquez EJ, Investigators O. Burden of medical co‐morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. European Journal Of Heart Failure 2019, 21: 373-381. PMID: 30698316, PMCID: PMC6818499, DOI: 10.1002/ejhf.1404.Peer-Reviewed Original ResearchConceptsCharlson co-morbidity indexCCI scoreSurgical revascularizationEjection fractionMedical therapySTICH trialHeart failureIschemic cardiomyopathyKansas City Cardiomyopathy QuestionnaireCo-morbidity indexCoronary artery bypassCo-morbid conditionsHealth-related qualityCoronary artery diseaseRisk of deathProportional hazards modelYears of ageTreatment effectsGreater functional limitationsArtery bypassCause mortalityIschemic etiologyArtery diseaseWalk testBaseline confounders
2016
Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis
Swede H, Sarwar A, Magge A, Braithwaite D, Cook LS, Gregorio DI, Jones BA, R. Hoag J, Gonsalves L, L. Salner A, Zarfos K, Andemariam B, Stevens RG, G. Dugan A, Pensa M, A. Brockmeyer J. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis. Cancer Causes & Control 2016, 27: 627-636. PMID: 27000206, PMCID: PMC5591028, DOI: 10.1007/s10552-016-0736-3.Peer-Reviewed Original ResearchConceptsCharlson co-morbidity indexRisk of deathBreast cancer patientsB patientsCCI scoreHazard ratioCancer patientsTriple-negative breast cancer subtypeTriple-negative breast cancer statusWhite breast cancer patientsCo-morbidity indexConnecticut Tumor RegistryEstimated hazard ratioBreast cancer statusBreast cancer subtypesAA/BCause mortalityClinicopathological factorsTumor RegistryAmerican/BlackCancer populationHigh prevalenceBreast cancerCohort analysisCancer status
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply